Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medicine Countermeasures

Solicitation Number: BARDA-CBRN-BAA-12-100-SOL-00011
Agency: Department of Health and Human Services
Office: Office of the Secretary
Location: Acquisitions Management, Contracts, & Grants (AMCG)
  • Print

Note:

There have been modifications to this notice. To view the most recent modification/amendment, click here
:
BARDA-CBRN-BAA-12-100-SOL-00011
:
Award
:
Added: Feb 17, 2012 3:11 pm Modified: Jul 20, 2012 4:44 pmTrack Changes
BARDA encourages the advanced research, development and acquisition of medical countermeasures such as vaccines, therapeutics, and diagnostics, as well as innovative approaches to meet the threat of CBRN agents in support of the preparedness mission and priorities of the HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) articulated in the PHEMCE Implementation Plan for CBRN Threats. The Implementation Plan is located on the ASPR website: http://www.phe.gov/about/amcg/ard/Pages/default.aspx.

In addition, the Pandemic and All Hazard Preparedness Act (PAHPA) directs BARDA to promote (i) innovations in technologies that may assist countermeasure and product advanced research and development (ii) research on and development of research tools and other devices and technologies and (iii) research to promote strategic initiations. The PAHPA is also located on the ASPR website: http://www.phe.gov/about/amcg/ard/Pages/default.aspx.


The purpose of this BAA is to solicit proposals that focus on one or more of the following areas of interest as listed here and further described in Part I.
Research Areas of Interest:


1. Vaccines Development
2. Antitoxins and Therapeutics
3. Antimicrobials and Antivirals
4. Radiological and Nuclear Agent Countermeasures
5. Chemical Agent Countermeasures
6. Diagnostics


BARDA anticipates that research and development activities awarded from this Broad Agency Announcement (BAA) will serve to advance the knowledge and scientific understanding of candidates' countermeasures for CBRN threats toward eventual FDA approval and their inclusion in the Strategic National Stockpile (SNS).


The Government intends to have a full & open competition for this requirement in the form of a BAA. The Government expects to make 1 or more awards, subject to the availability of funds.

Contact Information:


Comments to this announcement, referencing synopsis BARDA-CBRN-BAA-12-100-SOL-00011 may be submitted to CBRNBAA12.os@hhs.gov


Pre-proposal Conference:
The presentation slide show from Multi-BAA Pre-Proposal Conference (which was held on July 16, 2012 in Washington DC) is included as an attachment to this solicitation.

Added: May 24, 2013 2:08 pm
BARDA will support efficacy testing of solithromycin against anthrax and tularemia in animal models and will support development of a formulation that may be used in pediatric populations.
Please consult the list of document viewers if you cannot open a file.

Pre-proposal Conference Announcement

Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Pre-proposal Conference Announcement
Posted Date:
April 6, 2012
Description: A pre-proposal conference for the following BARDA BAAs will be held May 3, 2012:

BARDA-CBRN-BAA-12-100-SOL-00011
BARDA-SST-BAA-12-100-SOL-00013
BARDA-FLU--BAA-12-100-SOL-00018

These BAAs have not been issued as of 4/6/2012.
Description: Registration for foreign nationals who plan to attend the conference. Please follow the instructions on the information sheet for submission instructions.

Amendment 1

Type:
Mod/Amendment
Posted Date:
April 19, 2012
Description: The Pre-proposal Conference for the multiple Broad Agency Announcements to be issued by BARDA, scheduled for May 3rd, 2012, has been postponed due to circumstances beyond our control. Please continue to monitor FedBizOpps for an announcement once the meeting has been rescheduled. Foreign nationals will need to re-register. An updated form will be posted with the meeting announcement. Please do not register until a new meeting date has been posted. Thank you for your interest in the conference. We sincerely apologize for any inconvenience this may have caused.

Solicitation 1

Type:
Solicitation
Posted Date:
June 8, 2012
Description: Broad Agency Announcement - Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medicine Countermeasures

Amendment 2

Type:
Mod/Amendment
Posted Date:
June 20, 2012
Description: The purpose of this modification is to update registration and logistical information for the Multi-BAA Pre-Proposal Conference, scheduled for Monday, July 16, 2012, in Washington, DC. A website has been developed to provide for easier registration. In addition, the number of allowable participants has been increased to two (2) persons per company. Please see the attached modification for complete and updated registration information and conference logistics. Please note that those who have registered via the AMCG-Opportunities email do not need to re-register via the website.

Amendment 3

Type:
Mod/Amendment
Posted Date:
July 16, 2012
Amendment 3.docx (16.53 Kb)
Description: Amendment 3 to BARDA-CBRN-BAA-12-100-SOL-00011

Pre-Proposal Conference (7/16/12) slide show presentation

Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Pre-Proposal Conference (7/16/12) slide show presentation
Posted Date:
July 20, 2012
Description: Presentation slides from Multi-BAA Pre-Proposal Conference July 16, 2012, Washington DC.
The opening remarks ran about 30 minutes; the remainder of the time was devoted to one-on-one meetings between registrants and BARDA Program staff. There was no public Q&A session, so the information contained in the slides is the same that was available to all meeting attendees.

Amendment 4

Type:
Mod/Amendment
Posted Date:
May 1, 2013
Description: Amendment to Area of interest #6 (Diagnostics)
:
Office of the Assistant Secretary for Preparedness & Response (ASPR)
Department of Health and Human Services
330 Independence Ave. SW
G640
Washington, District of Columbia 20201
United States
:
Thomas P. Hastings-Tickerhoff,
Contracting Officer
Phone: 202.720.2823
:
Matthew A. McCord,
Contract Specialist
Phone: 202.260.0689